TY - JOUR
T1 - Robotic-assisted Versus Open Technique for Living Donor Kidney Transplantation
T2 - A comparison using propensity score matching for intention to treat
AU - Tinney, Francis
AU - Ivanics, Tommy
AU - Stracke, Joel
AU - Malinzak, Lauren
AU - Elsabbagh, Ahmed M.
AU - McEvoy, Tracci
AU - Nagai, Shunji
AU - Yoshida, Atsushi
N1 - Publisher Copyright:
Copyright © 2022 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.
PY - 2022/4/12
Y1 - 2022/4/12
N2 - Background. Living donor robotic-assisted kidney transplantation (RAKT) is an alternative to open kidney transplantation (OKT), but experience with this technique is limited in the United States. Methods. A retrospective review of living donor kidney transplants performed between 2016 and 2018 compared RAKT with OKT with regard to recipient, donor, and perioperative parameters. A 1:1 propensity score matching was performed on recipient/donor age, sex, body mass index, race, preoperative dialysis, and calculated panel reactive antibodies. Results. Outcomes of patient survival, graft survival, and postoperative complications were assessed for 139 transplants (47 RAKT and 92 OKT). Propensity score analysis (47:47) showed that RAKT recipients had longer warm ischemic times (49 versus 40min; P<0.001) and less blood loss (100 versus 150mL; P=0.005). Operative time and length of stay were similar between groups. Postoperative serum creatinine was similar during a 2-y follow-up. Post hoc analysis excluding 4 open conversions showed lower operative time with RAKT (297 versus 320min; P=0.04) and lower 30-d (4.7% versus 23.4%; P=0.02) and 90-d (7% versus 27.7%; P=0.01) Clavien-Dindo grade ≥3 complications. Conclusions. Our findings suggest that RAKT is a safe alternative to OKT.
AB - Background. Living donor robotic-assisted kidney transplantation (RAKT) is an alternative to open kidney transplantation (OKT), but experience with this technique is limited in the United States. Methods. A retrospective review of living donor kidney transplants performed between 2016 and 2018 compared RAKT with OKT with regard to recipient, donor, and perioperative parameters. A 1:1 propensity score matching was performed on recipient/donor age, sex, body mass index, race, preoperative dialysis, and calculated panel reactive antibodies. Results. Outcomes of patient survival, graft survival, and postoperative complications were assessed for 139 transplants (47 RAKT and 92 OKT). Propensity score analysis (47:47) showed that RAKT recipients had longer warm ischemic times (49 versus 40min; P<0.001) and less blood loss (100 versus 150mL; P=0.005). Operative time and length of stay were similar between groups. Postoperative serum creatinine was similar during a 2-y follow-up. Post hoc analysis excluding 4 open conversions showed lower operative time with RAKT (297 versus 320min; P=0.04) and lower 30-d (4.7% versus 23.4%; P=0.02) and 90-d (7% versus 27.7%; P=0.01) Clavien-Dindo grade ≥3 complications. Conclusions. Our findings suggest that RAKT is a safe alternative to OKT.
UR - http://www.scopus.com/inward/record.url?scp=85128998248&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85128998248&partnerID=8YFLogxK
U2 - 10.1097/TXD.0000000000001320
DO - 10.1097/TXD.0000000000001320
M3 - Article
C2 - 35434284
AN - SCOPUS:85128998248
SN - 2373-8731
VL - 8
SP - E1320
JO - Transplantation Direct
JF - Transplantation Direct
IS - 5
ER -